Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Purdue Pharma

A landmark appeals court ruling clears way for Purdue Pharma-Sackler bankruptcy deal

The 2nd Circuit Court of Appeals in New York cleared the way for a controversial bankruptcy deal that grants immunity from opioid lawsuits to members of the Sackler family.

WEKU

Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuits

A federal court ruling has cleared the way for OxyContin maker Purdue Pharma to settle thousands of legal claims over the toll of opioids

The Independent UK

King’s College London cuts ties with opioids-linked Sackler family

University is latest body to distance itself from sponsorship by owners of Purdue Pharma, makers of OxyContin

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Governments are increasingly reliant on consulting firms. Critics says it's often to their detriment

Critics say governments are outsourcing their own knowledge and activities to consulting firms, yet these firms aren't held to the same standards as the public sector.

ABC News

I’ve seen how overdose wrecks lives – why have the Sackler family members behind OxyContin avoided all charges?

I filmed as activists held Purdue Pharma’s owners to account. Yet the US government has utterly failed to play its part, says film-maker Laura Poitras

The Guardian - UK

Nan Goldin is going to the Oscars, and she wants to win

It’s not always emphasized given that she’s one of the most groundbreaking still photographers of the past 50 years

The Independent UK

'All the Beauty and the Bloodshed' chronicles Nan Goldin's career of art and activism

Filmmaker Laura Poitras and Goldin discuss their Oscar-nominated documentary about efforts to remove the Sackler family name from prominent museums amid the opioid epidemic.

WEKU

Read news from The Economist, FT, and more,
with one subscription

All the Beauty and the Bloodshed review: Nan Goldin documentary will leave you emotionally wrecked

The film weaves the artist’s fight with the Sackler family over the opioid crisis with her own tragic backstory

Evening Standard

US health agency accused of bowing to drug industry with new opioid guidance

Doctors say CDC’s softer guidelines ‘tossing aside’ safety limits put lives at risk as opioid epidemic continues to rage in the country

The Guardian - US

How one artist took on the Sacklers and shook their reputation in the art world

A new documentary All The Beauty and the Bloodshed tells the story of Nan Goldin, a photographer and activist who survived opioid addiction — then challenged members of the Sackler family.

WEKU

Artist Nan Goldin on addiction and taking on the Sackler dynasty: ‘I wanted to tell my truth’

Her battle against the billionaires who fuelled the opioid epidemic upended the art establishment. As a film about her life is released, she talks about family tragedy and her journey to activism

The Guardian - UK

When McKinsey Comes to Town review: the book to consult on opioids, China and more

Walt Bogdanich and Michael Forsythe of the New York Times have done their homework on the management giant

The Guardian - US

Ex-owner of Philly pharmacy that pushed more OxyContin than any other US drug store is sentenced to prison

PHILADELPHIA — The longtime owner of a Northeast Philadelphia pharmacy that once prescribed more OxyContin than any drug store in the country has been sentenced to prison and ordered to pay more than $4 million to settle claims of defrauding the government.

The Philadelphia Inquirer

How McKinsey cashed in by consulting for both companies and their regulators

When McKinsey Comes to Town authors Walt Bogdanich and Michael Forsythe say the consulting firm helped companies boost tobacco and opioid sales — while at the same time working for the FDA.

WEKU

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

V&A drops financial ties with Sackler family over links with opioids

London museum bows to years of pressure and removes signs bearing name of family associated with OxyContin crisis

St. Louis Post-Dispatch

Editorial: Alex Jones tries to hide his riches from the people whose lives he destroyed

As if to boost the brand of the League of Unrepentant Evildoers, Infowars founder Alex Jones has tried to join the likes of Purdue Pharma, Johnson & Johnson and the National Rifle Association in declaring bankruptcy as a way to evade multimillion-dollar court judgments against him. Jones is in the…

The Guardian - UK

Artists must expose corruption, urges director of documentary on opioid crisis

The story of Nan Goldin, a photographer who campaigned against the Sackler family’s Purdue Pharma, premieres at the Venice Film Festival

The Independent UK

Laura Poitras film spotlights activist photographer Goldin

Laura Poitras' Nan Goldin documentary "All the Beauty and the Bloodshed,” is having its world premiere at the Venice Film Festival on Saturday, where it is part of the main competition slate

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

J.D. Vance has a Purdue problem

The U.S. Senate candidate, who founded an anti-opioid non-profit, has several close ties to Purdue Pharma

WEKU

New book chronicles how America's opioid industry operated like a drug cartel

Two Washington Post journalists say pharmaceutical companies collaborated with each other — and with lawyers and lobbyists — to create laws to protect the industry. Their new book is American Cartel.

The Conversation

The opioid crisis isn’t just the Sacklers’ fault – and making Purdue Pharma pay isn’t enough on its own to fix the pharmaceutical industry’s deeper problems

You may have heard of the Sackler family and the role that they and their privately held company, Purdue Pharma, played in the opioid crisis. One TV series depicting the family as a villainous clan has earned 14 Emmy nominations. Another is in the works.

The Conversation

$150M is not enough: Canada’s proposed Purdue Pharma settlement for opioid damages is paltry and won’t prevent future crises

On June 29, Canadian federal and provincial governments reached a proposed $150-million settlement with Purdue Pharma Canada, makers of OxyContin, an opioid-based pain medication. The settlement is intended to recover the health-care costs related to the damaging effects from the sale and marketing of OxyContin.

St. Louis Post-Dispatch

Lynn Schmidt: America's addiction nightmare comes home

A few weeks ago, my husband and I lost a friend to an opioid overdose. He was not the first person we knew who died from an overdose, but he was perhaps the closest. And while I am still working through the five stages of grief (denial, anger, bargaining, depression…

The Guardian - US

Ohio judge hears if pharmacy chains should pay for driving opioid crisis

CVS, Walgreens and Walmart Were found to recklessly dispense narcotic painkillers in two Ohio counties, fueling a drug epidemic

Tribune News Service

Purdue Pharma squares off with DOJ Over $6 billion OxyContin deal

A $6 billion deal hangs in the balance as OxyContin maker Purdue Pharma LP and its wealthy owners square off against the U.S. Justice Department over the firm’s opioid lawsuit settlement.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.